CTCF and metabolic dysfunction-associated steatotic liver disease: As shown in Figures 1C,D, to study the molecular regulation mechanism of CTCF in the pathological process of NAFLD, we designed three siRNAs targeting CTCF and used RT-qPCR and Western blot to detect the mRNA and protein expression levels of CTCF and DPP4, respectively.